Phil Pharmawealth/Karnataka Furosemide

Phil Pharmawealth/Karnataka Furosemide

furosemide

Manufacturer:

Karnataka

Distributor:

Phil Pharmawealth
Full Prescribing Info
Contents
Furosemide.
Description
Each mL contains: Furosemide 10 mg.
Indications/Uses
Furosemide is a diuretic recommended for use when prompt and effective diuresis is required.
The intravenous formulation is appropriate for use in emergencies or when oral therapy is precluded. Indications include cardiac, pulmonary, hepatic and renal edema.
Dosage/Direction for Use
Furosemide injection must always be given slowly.
The diuretic effect of Furosemide is proportional to dosage. Doses of 20-40 mg intramuscularly or intravenously may be given initially. If larger doses are required, they should be given by slow infusion and titrated according to the response.
Children: Parenteral doses for children range from 0.5-1.5 mg/kg body weight daily up to a maximum total daily dose of 20 mg.
Elderly: In the elderly, Furosemide is generally eliminated more slowly. Dosage should be titrated until the required responses is achieved.
Overdosage
In case of overdose, there is danger of dehydration and electrolyte depletion due to excessive diuresis. Treatment should be aimed at fluid replacement and correction of the imbalance.
Contraindications
Furosemide is contraindicated in anuria, electrolyte deficiency and pre-comatose states associated with liver cirrhosis. It is contraindicated to patients with hypersensitivity to Furosemide or Sulfonamides.
Warnings
Intravenous injection of Furosemide must always be given slowly, i.e. at the rate not exceeding4 mg/minute.
Patients with prostatic hypertrophy or impairment of micturition have an increased risk of developing acute retention.
Where indicated, steps should be taken to correct hypotension or hypovolemia before commencing therapy.
Opened ampoule should be used immediately and excess should be discarded.
Special Precautions
Caution should be observed in patients liable to electrolyte deficiency. Result of animal work in general, show no hazardous effect of Furosemide in pregnancy. There is clinical evidence of safety of the drug in the third trimester of human pregnancy, however, Furosemide should be used with caution in nursing mothers.
Nursing mothers: As Furosemide may inhibit lactation or may pass into breast milk, it should be used with caution in nursing mothers. Injection of Furosemide should not be mixed with any other preparations.
Adverse Reactions
Furosemide is generally well tolerated. Side effects of a minor nature such as nausea, malaise or gastric upset occur but are not usually severe enough to necessitate withdrawal of treatment. Serum Calcium levels may be reduced, in very rare case there has been observed Nephrocalcinosis has been reported in premature infants.
The indications of allergic reactions, such as skin rashes, photosensitivity, vasculitis, fever, interstitial nephritis or shock, is very slow but when these occur, treatment should be withdrawn. Standard measures for the treatment of shock should be taken if necessary.
Isolated cases of acute pancreatitis have been reported after long term diuretic (including Furosemide) treatment. Disorder of hearing after Furosemide are rare, and in most cases reversible. They may occur if Furosemide is injected too rapidly, particularly in patients with renal insufficiency.
As with other diuretics, a transient rise in creatinine and urea levels has been reported with Furosemide. In common with other sulfonamide-based diuretics hyperuricaemia may occur and in rare cases, clinical gout may be precipitated.
Bone marrow depression has been reported as a rare complication and necessitates withdrawal of treatment. Preexisting metabolic alkalosis (e.g. decompensated cirrhosis of the liver) may be aggravated by Furosemide treatment.
Reduced mental alertness may impair ability to drive or operate dangerous machinery.
Storage
Store at temperatures not exceeding 25°C.
MIMS Class
Diuretics
ATC Classification
C03CA01 - furosemide ; Belongs to the class of high-ceiling sulfonamide diuretics.
Presentation/Packing
Form
Phil Pharmawealth/Karnataka Furosemide soln for inj 10 mg/mL
Packing/Price
2 mL x 10 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in